As the majority of individuals with<unk>  have cirrhosis, much of the epidemiological data on<unk>  comes from the cirrhotic population. The condition is quite common: approximately 10% of individuals admitted to hospital with ascites have<unk> . A retrospective case series of cirrhotic patients treated with terlipressin suggested that 20.0% of acute kidney failure in cirrhotics was due to type 1<unk> , and 6.6% was due to type 2<unk> . It is estimated that 18% of individuals with cirrhosis and ascites will develop<unk>  within one year of their diagnosis with cirrhosis, and 39% of these individuals will develop<unk>  within five years of diagnosis. Three independent risk factors for the development of<unk>  in cirrhotics have been identified: liver size, plasma renin activity, and serum sodium concentration. The prognosis of these patients is grim with untreated patients having an extremely short survival. The severity of liver disease (as evidenced by the MELD score) has been shown to be a determinant of outcome. Some patients without cirrhosis develop<unk> , with an incidence of about 20% seen in one study of ill patients with alcoholic hepatitis.
Hepatorenal syndrome
Conorenal syndrome
Papillorenal syndrome
Nephritic syndrome
Cardiorenal syndrome
Hemolytic–uremic syndrome
Dialysis disequilibrium syndrome
Acute uric acid nephropathy